Moreover, in endometrial atypical hyperplasia, which demonstrates heterogeneous and patchy loss of ARID1A, higher immunoreactivity for phospho-H2AX, a marker for DSBs, was found in ARID1A-negative tumor foci than in areas with intact ARID1A expression. The gene discussed is ARID1A; the disease is neoplasm.